Genetic Determinants of Variability in Response to Testorsterone Administration in Men
11/01/2011 - 10/31/2013 (PI)Eli Lilly and Company
Effects of Testosterone Replacement on Artherosclerosis Progression and Physical Function in Older Men with Low Testosteron Levels
09/01/2005 - 10/31/2013 (PI)Solvay Pharmaceuticals, Inc.
Determination of Minimal Clinically Important Differences in Physical Function Measures in Older Individuals
02/05/2007 - 12/31/2012 (PI)Merck & Company, Inc.
A placebo-controlled, multiple ascending dose study to evaluate SAFETY, tolerability, pharmacokinetics and pharmacodynamics of LGD-4033 (an oral selective androgen receptor modulator) in healthy
02/01/2010 - 12/31/2011 (PI)Ligand Pharmaceuticals, Inc.
Pepper Grant- Bhasin Boston OAIC: A Translational Approach to Function Promoting Anabolic Therapies
09/01/2008 - 05/31/2016 (PI)NIH-NIA5P30 AG031679-05
Metabolism Endocrinology and Obesity Training Grant
05/01/2008 - 06/30/2014 (PI)NIH-NIDDK5T32 DK007201-35
Racial disparities in fall risk and bone strength among men
05/15/2009 - 04/30/2014 (PI)New England Res Inst NIH-NIA
Optimizing Protein Intake in Older Americans with Mobility Limitations
09/15/2010 - 08/31/2013 (PI)NIH-NIA5R01 AG037547-04
The Bone Trial of the Testosterone Trial
09/01/2011 - 07/31/2013 (PI)University of Pennsylvania NIH-NIA
Mechanism of Myostatin Action
03/09/2009 - 05/02/2013 (PI)NIH-NIDDK5R01 DK078512-05
Testosterone Trial - PK Supplement
06/01/2012 - 04/30/2013 (PI)University of Pennsylvania NIH-NIA
05/15/2009 - 04/30/2013 (PI)University of Pennsylvania NIH-NIA
Mechanisms of Testosterone Action
02/01/2010 - 02/02/2013 (PI)NIH-NIA5R01 AG037193-09
Population-Based Reference Ranges for Estradiol and Estrone in Men
04/07/2012 - 07/31/2012 (PI)NIH-NIDDK1R01 DK092938-01A1
Showing 10 of 27 results.
Show All Results